TriangleNCT00354172 · OUTCOME
Number of Patients Who Were Disease-free and Alive at 24 Months
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 24 Months Post transplant
What was measured
Number of patients who were alive and free of disease (malignancy) at 24 months after transplant.
Groups in this outcome
Evaluable Patients
All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
| Group | Source count |
|---|---|
| Evaluable Patients | 15 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Evaluable Patients | 0 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- anticipated Posting Date
- 2009-11
- classes
- categories
- measurements
- group Id
- OG000
- value
- 0
- denoms
- counts
- group Id
- OG000
- value
- 15
- units
- Participants
- description
- Number of patients who were alive and free of disease (malignancy) at 24 months after transplant.
- groups
- description
- All patients receiving full study treatment with chemotherapy and radiation, along with natural killer cells, aldesleukin and umbilical cord blood transplant.
- id
- OG000
- title
- Evaluable Patients
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- 24 Months Post transplant
- title
- Number of Patients Who Were Disease-free and Alive at 24 Months
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice